PT1371375E - Vacina para a protecção de animais contra a leishmaníase âmbito técnico - Google Patents
Vacina para a protecção de animais contra a leishmaníase âmbito técnico Download PDFInfo
- Publication number
- PT1371375E PT1371375E PT02702414T PT02702414T PT1371375E PT 1371375 E PT1371375 E PT 1371375E PT 02702414 T PT02702414 T PT 02702414T PT 02702414 T PT02702414 T PT 02702414T PT 1371375 E PT1371375 E PT 1371375E
- Authority
- PT
- Portugal
- Prior art keywords
- leishmania
- vaccine
- animals against
- protect animals
- against leishmania
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000222722 Leishmania <genus> Species 0.000 title 1
- 241001137872 Leishmania sp. Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 241000222697 Leishmania infantum Species 0.000 abstract 1
- 208000004554 Leishmaniasis Diseases 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200100402A ES2171360B1 (es) | 2001-02-21 | 2001-02-21 | Vacuna para la proteccion de animales frente a la leishmania. |
| ES200102057A ES2172482B1 (es) | 2001-02-21 | 2001-09-12 | Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania". |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1371375E true PT1371375E (pt) | 2009-10-12 |
Family
ID=26156220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02702414T PT1371375E (pt) | 2001-02-21 | 2002-02-21 | Vacina para a protecção de animais contra a leishmaníase âmbito técnico |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1371375B1 (pt) |
| AT (1) | ATE439858T1 (pt) |
| DE (1) | DE60233391D1 (pt) |
| ES (1) | ES2334493T3 (pt) |
| PT (1) | PT1371375E (pt) |
| WO (1) | WO2002066054A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006058243A2 (en) * | 2004-11-24 | 2006-06-01 | Yale University | Leishmania antigens and related compositions and uses |
-
2002
- 2002-02-21 EP EP02702414A patent/EP1371375B1/en not_active Expired - Lifetime
- 2002-02-21 DE DE60233391T patent/DE60233391D1/de not_active Expired - Lifetime
- 2002-02-21 AT AT02702414T patent/ATE439858T1/de not_active IP Right Cessation
- 2002-02-21 PT PT02702414T patent/PT1371375E/pt unknown
- 2002-02-21 WO PCT/ES2002/000077 patent/WO2002066054A1/es not_active Ceased
- 2002-02-21 ES ES02702414T patent/ES2334493T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60233391D1 (de) | 2009-10-01 |
| EP1371375A1 (en) | 2003-12-17 |
| ATE439858T1 (de) | 2009-09-15 |
| ES2334493T3 (es) | 2010-03-11 |
| WO2002066054A1 (es) | 2002-08-29 |
| EP1371375B1 (en) | 2009-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0118249D0 (en) | Histidine vaccines | |
| ATE451119T1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| WO2002096363A3 (en) | Method for treating fibrotic diseases or other indications | |
| WO2004098491A3 (en) | METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES | |
| ATE250937T1 (de) | Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa | |
| BRPI9912663B1 (pt) | vacina contra cáncer e polipeptìdeo. | |
| MXPA05009580A (es) | Vacuna contra el virus de la influenza. | |
| PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
| DK1216053T3 (da) | Influenzavaccine | |
| WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
| NZ547776A (en) | Modified vaccinia virus ankara for protecting an animal against an antigen or self-protein | |
| ATE270707T1 (de) | Entepneumovirus und entsprechendes impfstoff | |
| WO2003059385A3 (en) | Hiv vaccine and method of use | |
| WO2002096362A3 (en) | Method for treating fibrotic diseases or other indications vi | |
| NO20011193L (no) | Vaksine mot seksuelt overförbare sykdommer | |
| WO2003083083A3 (en) | Methods of using flt3-ligand in immunization protocols | |
| MXPA03009763A (es) | Vacuna contra el virus de la enfermedad de la fiebre aftosa. | |
| WO2001068865A3 (en) | Fish vaccine against piscirickettsia salmonis | |
| PT1371375E (pt) | Vacina para a protecção de animais contra a leishmaníase âmbito técnico | |
| EA200301151A1 (ru) | Вакцина против натуральной оспы | |
| BRPI0412913A (pt) | meio para tratamento de infecções por leishmaniose | |
| ES2172482A1 (es) | Adicion de la patente es 200100402 vacuna para la proteccion de perros frente a leishmania | |
| WO2001022994A3 (en) | Vaccines against neisseria infection | |
| WO2003032917A3 (en) | Hookworm vaccine | |
| WO2007121491A8 (en) | Hcv vaccinations |